NASDAQ · Medical - Devices

ARAY (ARAY) Stock

$0.28 +0.81% NASDAQ: ARAY Healthcare

Valuation

MetricValue
Price$0.28
Market Cap$33.90M
P/E Ratio-15.50
P/B Ratio0.45
P/S Ratio0.09
EPS (TTM)$0.00
52-Week High$2.10
52-Week Low$0.23
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-2.47%
ROA-0.43%
ROCE9.88%
Gross Margin1.74%
Operating Margin1.74%
Net Margin-10.76%
Debt/Equity4.37
Current Ratio1.64

Annual Financials (USD)

Metric20212022202320242025
Revenue$396.0M$430.0M$448.0M$447.0M$459.0M
Operating Profit$22.0M$8.0M$2.0M$1.0M$8.0M
Net Profit$-6.0M$-5.0M$-9.0M$-16.0M$-2.0M
EPS$-0.07$-0.06$-0.10$-0.16$-0.02
Op Margin5.6%1.9%0.5%0.1%1.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$480.0M$473.0M$479.0M$469.0M$470.0M
Total Liabilities$411.0M$420.0M$426.0M$424.0M$389.0M
Cash$116.0M$89.0M$89.0M$69.0M$57.0M
Borrowings$199.0M$199.0M$205.0M$211.0M$176.0M

Latest News

Accuray (ARAY) Stock Sees Fair Value Cut After Downgrades And Lower Growth Assumptions Simply Wall St. · Jun 27, 2026 Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules PR Newswire · May 29, 2026 Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer PR Newswire · May 15, 2026 Accuray Inc (ARAY) Runs Into Middle East Headwinds, But Shift Plan Is Working Insider Monkey · May 12, 2026 Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls The Fly · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$39.0M$-2.0M$16.0M$-12.0M$3.0M
Investing Cash Flow$-5.0M$-9.0M$-25.0M$-7.0M$-17.0M
Financing Cash Flow$-11.0M$0$0$0$-13.0M
Net Cash Flow$8.0M$-28.0M$1.0M$-21.0M$-8.0M
Free Cash Flow$36.0M$-7.0M$3.0M$-16.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA11.11
FCF Yield-79.30%
Quick Ratio0.66
Interest Coverage0.62
Return 1Y-79.42%
Return 3Y-92.80%
Return 5Y-93.21%

Ownership

Insiders Held4.35%
Institutions Held69.38%
Institutions Float Held72.53%
Institutional HolderSharesReport Date
TCW Group, Inc.15,467,9522026-03-31
Blackrock Inc.8,458,4092026-03-31
Neuberger Berman Group, LLC5,855,0642026-03-31
Armistice Capital, LLC5,636,0002026-03-31
Weber Capital Management LLC /ADV5,055,2942026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANIK $19.61 -5.43% -19.58 $262.44M 0.00%
AVR $8.28 +0.00% -2.56 $304.61M 0.00%
LNSR $5.25 -1.87% 6.53 $63.55M 0.00%
MIST $1.13 -2.59% -2.00 $97.05M 0.00%
MXCT $1.18 +6.31% -2.55 $126.40M 0.00%

About ARAY

ARAY is led by CEO Stephen R. LaNeve, employs 987 people, headquartered in US, publicly traded since 2007.

ARAY stock trades at $0.28 with a market capitalization of $33.90M. The stock is valued at a price-to-earnings (P/E) ratio of -15.50, price-to-book of 0.45, price-to-sales of 0.09. Over the past 52 weeks the stock has ranged between $0.23 and $2.10, and currently trades 86.7% below its 52-week high.

On profitability, ARAY generates a return on equity (ROE) of -2.47%, return on capital employed of 9.88%, an operating margin of 1.74%, a net profit margin of -10.76%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides